Institutional Ownership
Phio Pharmaceuticals Corp
CUSIP 71880W501COM NEWPHIOQ1 2026
13D / 13G Filings
15
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
10.0%
Max % of class reported
Institutional Holders
22
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
15 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Cvi Investments, Inc. | 13G/A | 9.9% | 1.19M | SEC |
| 2 | Feb 13, 2026 | Mitchell P. Kopin | 13G/A | 9.1% | 1.14M | SEC |
| 3 | Dec 11, 2025 | Orca Capital AG | 13G/A | 4.9% | 538.7K | SEC |
| 4 | Nov 24, 2025 | Orca Capital AG | 13G/A | 6.5% | 700.4K | SEC |
| 5 | Nov 12, 2025 | Orca Capital AG | 13G/A | 4.9% | 409.3K | SEC |
| 6 | Nov 10, 2025 | Cvi Investments, Inc. | 13G | 9.9% | 733.3K | SEC |
| 7 | Nov 7, 2025 | Mitchell P. Kopin | 13G/A | 7.0% | 430.0K | SEC |
| 8 | Nov 6, 2025 | Orca Capital AG | 13G/A | 9.8% | 800.0K | SEC |
| 9 | Aug 7, 2025 | Orca Capital AG | 13G/A | 4.9% | 280.6K | SEC |
| 10 | Feb 7, 2025 | Cvi Investments, Inc. | 13G/A | 4.9% | 91.0K | SEC |
5 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Phio Pharmaceuticals Corp.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 147.3K | $179.6K |
| 2 | Jane Street Group, LLC | 119.2K | $145.4K |
| 3 | Cetera Investment Advisers | 45.0K | $54.9K |
| 4 | Two Sigma Investments, LP | 32.5K | $39.6K |
| 5 | Scientech Research LLC | 30.0K | $36.6K |
| 6 | Ubs Group AG | 27.0K | $32.9K |
| 7 | Xtx Topco Ltd | 24.9K | $30.3K |
| 8 | Northern Trust Corp | 23.8K | $29.0K |
| 9 | Two Sigma Securities, LLC | 15.2K | $18.6K |
| 10 | Captrust Financial Advisors | 10.0K | $12.2K |